Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jason J. Marineau"'
Autor:
Ashraf Wilsily, Robert Zahler, Nan Ke, Claudio Chuaqui, Michael J. Bradley, Jason J. Marineau, Goran Malojčić, Stephane Ciblat, Anneli Savinainen, Darby Schmidt, Nigel J. Waters, Kristin B. Hamman, Sydney Alnemy, Stephanie Roy, Dana K. Winter, Anzhelika Kabro, Kenneth Matthew Whitmore, Shanhu Hu, Janessa Mihalich
Publikováno v:
Journal of medicinal chemistry. 65(2)
CDK7 has emerged as an exciting target in oncology due to its roles in two important processes that are misregulated in cancer cells: cell cycle and transcription. This report describes the discovery of SY-5609, a highly potent (sub-nM CDK7 Kd) and s
Autor:
Nan Ke, Yoon Jong Choi, David A. Orlando, Emmanuelle di Tomaso, Kevin Sprott, Christian Fritz, Shanhu Hu, Michael J. Bradley, John Carulli, Darby Schmidt, Eric R. Olson, Stephane Ciblat, Nisha Rajagopal, Jason J. Marineau, J. Graeme Hodgson, Dana K. Winter, Anzhelika Kabro, Yixuan Ren, Kristin B. Hamman, Sydney Alnemy, Liv Johannessen
Publikováno v:
Cancer Research. 79:3479-3491
Recent studies suggest that targeting transcriptional machinery can lead to potent and selective anticancer effects in cancers dependent on high and constant expression of certain transcription factors for growth and survival. Cyclin-dependent kinase
Autor:
Goran Malojčić, Martine Brault, Ines H. Kaltheuner, Lewis C. Cantley, Patrick Deroy, Heeyoun Bunch, Shanhu Hu, Janet Iwasa, Robin D. Dowell, Michael J. Bradley, Christian Clavette, Limei Tao, Peter W. White, Matthias Geyer, Zachary C. Poss, William M. Old, Zachary L. Maas, Shraddha Nayak, Tim-Michael Decker, Christopher C. Ebmeier, Benjamin Erickson, Leah J. Damon, David Bentley, Jenna K. Rimel, Tomer M. Yaron, Jason J. Marineau, Jared L. Johnson, Kristin B. Hamman, Dylan J. Taatjes
Publikováno v:
Genes Dev
CDK7 associates with the 10-subunit TFIIH complex and regulates transcription by phosphorylating the C-terminal domain (CTD) of RNA polymerase II (RNAPII). Few additional CDK7 substrates are known. Here, using the covalent inhibitor SY-351 and quanti
Autor:
Nan Ke, Anneli Savinainen, Liv Johannessen, Shanhu Hu, Anthony D'Ippolito, Jason J. Marineau, Graeme Hodgson, Nisha Rajagopal, William C. Zamboni
Publikováno v:
Molecular Cancer Therapeutics. 18:C091-C091
Introduction: CDK7 is a key regulator of transcription and cell cycle progression and has been implicated in multiple tumor types driven by aberrant transcriptional control (e.g. MYC-, ESR1-activation) and/or aberrant cell cycle control (e.g. RB1, CC
Autor:
James E. Bradner, Dennis L. Buckley, Wei Zhang, Harry Fu, Michael R. McKeown, Jason J. Marineau, Stephen C. Blacklow, Yibo Huang, Xiang Xu, Asha Kadam, Zijuan Zhang, Daniel L. Shaw, Xiaofeng Zhang, Jun Qi, Shuai Liu
Publikováno v:
Journal of Medicinal Chemistry
BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer. Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands
Autor:
Luis E. N. Quadri, Poornima Mohandas, Alberto Munoz, Jason J. Marineau, James E. Bradner, William B. Smith, Andrew S. Au, Michael P. D'Erasmo, Ryan P. Murelli
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:4035-4038
7,9-Diaryl-1,6,8-trioxaspiro[4.5]dec-3-en-2-ones are a recently described group of spirocyclic butenolides that can be generated rapidly and as a single diastereomer through a cascade process between γ-hydroxybutenolides and aromatic aldehydes. The
Autor:
Alex Kentsis, A. Thomas Look, James E. Bradner, Frederic Baleydier, Ruta Grebliunaite, Jon C. Aster, Huipin Yuan, Andrew P. Weng, Françoise Pflumio, Li Pan, Lynn VerPlank, Jason J. Marineau, Stephanie Norton, Richard W.J. Groen, Frank An, Jason Burbank, Benjamin Uzan, Constantine S. Mitsiades, Hanno Steen, Sandrine Poglio, Nicola Tolliday, Casie Reed, Elena Kozakewich, Paul A. Clemons, Alejandro Gutierrez
Publikováno v:
Journal of Clinical Investigation, 124(2), 644-55. The American Society for Clinical Investigation
Gutierrez, A, Pan, L, Groen, R W J, Baleydier, F, Kentsis, A, Marineau, J, Grebliunaite, R, Kozakewich, E, Reed, C, Pflumio, F, Poglio, S, Uzan, B, Clemons, P, VerPlank, L, An, F, Burbank, J, Norton, S, Tolliday, N, Steen, H, Weng, A P, Yuan, H, Bradner, J E, Mitsiades, C, Look, A T & Aster, J C 2014, ' Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia ', Journal of Clinical Investigation, vol. 124, no. 2, pp. 644-55 . https://doi.org/10.1172/JCI65093
Gutierrez, A, Pan, L, Groen, R W J, Baleydier, F, Kentsis, A, Marineau, J, Grebliunaite, R, Kozakewich, E, Reed, C, Pflumio, F, Poglio, S, Uzan, B, Clemons, P, VerPlank, L, An, F, Burbank, J, Norton, S, Tolliday, N, Steen, H, Weng, A P, Yuan, H, Bradner, J E, Mitsiades, C, Look, A T & Aster, J C 2014, ' Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia ', Journal of Clinical Investigation, vol. 124, no. 2, pp. 644-55 . https://doi.org/10.1172/JCI65093
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC. Here, we performed 2 complementary screens to identify FDA-approved drugs and drug-like sm
Autor:
James E. Bradner, Jason J. Marineau, Peter B. Rahl, Alla A. Sigova, Matthew G. Guenther, Zi Peng Fan, Jakob Lovén, Lars Anders, Richard A. Young, William B. Smith, Tong Ihn Lee, Jun Qi
Publikováno v:
Nature Biotechnology. 32:92-96
A vast number of small-molecule ligands, including therapeutic drugs under development and in clinical use, elicit their effects by binding specific proteins associated with the genome. An ability to map the direct interactions of a chemical entity w
Autor:
Michael Xiang, Jason J. Marineau, Sarah R. Walker, Daniel L. Shaw, Traci M. Blonquist, Richard Stone, Haesook T. Kim, Vincent T. Ho, Suhu Liu, Robert J. Soiffer, Zachary T. Giaccone, Yasmin Kroll, Donna Neuberg, Lisa N. Heppler, David A. Frank, Melodi Anahtar, James E. Bradner, Michal Bar-Natan, Darwin Q. Ye, Patricia A. Toniolo, Nichole Jones, Claudio Hetz
Publikováno v:
Blood
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
The oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently activated inappropriately in a wide range of hematological and solid cancers, but clinically available therapies targeting STAT3 are lacking.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8349c064b881a05ac4767213f8968b6e
Publikováno v:
Analytical chemistry. 87(12)
Analysis of complex mixtures of proteins by hydrogen exchange (HX) mass spectrometry (MS) is limited by one's ability to resolve the protein(s) of interest from the proteins that are not of interest. One strategy for overcoming this problem is to tag